High-throughput crystallographic screening device and method for crystalizing membrane proteins using a sub physiological resting membrane potential across a lipid matrix of variable composition

US2022274101A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022274101-A1
Application numberUS-202217741595-A
CountryUS
Kind codeA1
Filing dateMay 11, 2022
Priority dateJun 29, 2016
Publication dateSep 1, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention is a high-throughput voltage screening crystallographic device and methodology that uses multiple micro wells and electric circuits capable of assaying different crystallization condition for the same or different proteins of interest at the same of different voltages under a humidity and temperature controlled environment. The protein is solubilized in a lipid matrix similar to the lipid composition of the protein in the native environment to ensure stability of the protein during crystallization. The invention provides a system and method where the protein is transferred to a lipid matrix that holds a resting membrane potential, which reduces the degree of conformational freedom of the protein. The invention overcomes the majority of the difficulties associated with vapor diffusion techniques and essentially reconstitutes the protein in its native lipid environment under “cuasi” physiological conditions.

First claim

Opening claim text (preview).

What is claimed is: 1 . A system for membrane protein crystallization comprising: a sample unit having: a sample holding layer having a plurality of holding wells, wherein each holding well comprises a pair of electrodes, and a lid layer provided over said plurality of holding wells to seal the contents of said plurality of holding wells from each other; and a variable direct current potential source electrically coupled to the pair of electrodes of each holding well. 2 . The system of claim 1 , further comprising: an incubator receiving the sample unit; a temperature unit monitoring and controlling a temperature inside the incubator; and a humidity unit monitoring and controlling a humidity inside said incubator. 3 . The system of claim 1 , wherein the variable potential source is configured to alter a direction of a potential field generated between the pair of electrodes of each holding well, wherein the direction of the potential field generated varies within 180 degrees. 4 . The system of claim 1 , wherein the plurality of holding wells has the same geometric shape or different geometric shapes. 5 . The system of claim 1 , wherein said lid layer comprises a plurality of lid wells having the same shape and dimensions as said holding wells. 6 . The system of claim 1 , wherein the pair of electrodes has the same geometric shape in every holding well. 7 . The system of claim 1 , wherein at least one holding well has a pair of electrodes having a geometric shape different than the pair of electrodes ends of said plurality of holding wells. 8 . The system of claim 1 , wherein said variable direct current potential source provides the same variable direct current potential to the pair of electrodes ends of all holding wells. 9 . The system of claim 1 , wherein said variable direct current potential source provides different variable direct current potentials to the pair of electrodes ends of different holding wells. 10 . The system of claim 1 , wherein said sample unit comprises at least one membrane protein sample, and wherein said at least one membrane protein sample comprises solubilized membrane protein complex. 11 . The system of claim 10 , wherein said at least one membrane protein sample is provided in a lipid matrix. 12 . The system of claim 11 , wherein said lipid matrix has a lipid composition similar to the lipid composition of the membrane protein in the native environment or is varied by lipid doping. 13 . The system of claim 1 , wherein said sample unit comprises a plurality of membrane protein samples of the same membrane protein. 14 . The system of claim 1 , wherein said sample unit comprises a plurality of membrane protein samples of different membrane proteins. 15 . The system of claim 1 , wherein said potential source provides to the pair of electrodes ends of the holding wells a potential selected from: a subphysiological membrane potential, a physiological membrane potential and a supra-physiological membrane potential. 16 . The system of claim 1 , wherein said potential source varies a waveform of said potential. 17 . A system for membrane protein crystallization comprising: a sample unit having: a sample holding layer having a plurality of holding wells, wherein each holding well comprises a pair of electrodes, and a lid layer provided over said plurality of holding wells to seal the contents of said plurality of holding wells from each other; a variable direct current potential source electrically coupled to the pair of electrodes of each holding well; wherein the variable potential source is configured to alter the intensity of a potential field generated between the pair of electrodes of each holding well. 18 . The system of claim 17 , wherein the alteration in intensity of a potential field occurs at a range of potential from −140 mV to 10 mV. 19 . The system of claim 17 , wherein the variable potential source is configured to alter a direction of a potential field generated between the pair of electrodes of each holding well, wherein the direction of the potential field generated varies within 180 degrees. 20 . The system of claim 17 , wherein a temperature unit and a humidity unit control the temperature and humidity conditions during a crystallization process of a membrane protein sample contained within a holding well of said sample unit. 21 . The system of claim 20 , wherein at least one of: the potential source, the temperature unit and the humidity unit is integrated into an incubator. 22 . The system of claim 17 , wherein said lid layer comprises a plurality of lid wells having the same shape and dimensions as said holding wells. 23 . The system of claim 17 , wherein said variable direct current potential source provides the same variable direct current potential to the pair of electrodes ends of all holding wells. 24 . The system of claim 18 , wherein said sample unit comprises at least one membrane protein sample, and wherein said at least one membrane protein sample comprises solubilized membrane protein complex. 25 . A system for membrane protein crystallization comprising: a sample unit having: a sample holding layer having a plurality of holding wells, wherein each holding well comprises a pair of electrodes, and a lid layer provided over said plurality of holding wells to seal the contents of said plurality of holding wells from each other; a variable direct current potential source electrically coupled to the pair of electrodes of each holding well; wherein the variable potential source is configured to alter the intensity of a potential field generated between the pair of electrodes of each holding well more than one hour after the first variation in the potential field. 26 . The system of claim 25 , wherein the potential is altered to a range from −5 mV to −20 mV after 1-2 hours in a range from −140 mV to 10 mV. 27 . The system of claim 25 , wherein the variable potential source is configured to alter a direction of a potential field generated between the pair of electrodes of each holding well, wherein the direction of the potential field generated varies within 180 degrees. 28 . The system of claim 25 , wherein said sample unit comprises a plurality of membrane protein samples of the same membrane protein. 29 . The system of claim 25 , wherein said sample unit comprises a plurality of membrane protein samples of different membrane proteins. 30 . The system of claim 25 , wherein said potential source provides to the pair of electrodes ends of the holding wells a potential selected from: a subphysiological membrane potential, a physiological membrane potential and a supra-physiological membrane potential. 31 . The system of claim 25 , wherein said sample unit comprises at least one membrane protein sample, and wherein said at least one membrane protein sample comprises solubilized membrane protein complex.

Assignees

Inventors

Classifications

  • Organic compounds · CPC title

  • Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays (synthesis methods per se C40B50/00) · CPC title

  • by crystallization · CPC title

  • Membrane reactors (catalytic membranes B01J35/59; membranes B01D71/00) · CPC title

  • Libraries containing peptides or polypeptides, or derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022274101A1 cover?
The invention is a high-throughput voltage screening crystallographic device and methodology that uses multiple micro wells and electric circuits capable of assaying different crystallization condition for the same or different proteins of interest at the same of different voltages under a humidity and temperature controlled environment. The protein is solubilized in a lipid matrix similar to t…
Who is the assignee on this patent?
Univ Puerto Rico
What technology area does this patent fall under?
Primary CPC classification B01J19/0046. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Thu Sep 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).